Bringing science and development together through news and analysis

Developing nations now dominate GM crop production
  • Developing nations now dominate GM crop production

Copyright: GMB Akash / Panos

Speed read

  • Of the 28 countries with GM crops, 20 are developing ones

  • Adoption rate has grown 100-fold since biotech crops were first planted in 1996

  • Two South-East Asian nations — Philippines and Myanmar — are among top growers

Shares
[MANILA] The United States remains the leading grower of biotech crops in the world but developing countries are fast catching up.

In the latest annual report of the International Service for the Acquisition of Agri-biotech Applications (ISAAA), which supports the commercialisation of biotech products, 20 of the 28 countries which grow biotech crops are developing countries in Latin America, Africa and Asia including two South-East Asian nations.

“For the third consecutive year, developing countries planted more biotech crops than industrial countries,” said Rhodora Aldemita, ISAAA senior program officer who presented the report to Philippine media last 27 February in Makati City.

Developing countries now account for 96 million hectares of land planted to biotech crops, representing nearly 53 per cent of the global total of 181.5 million hectares.

The US remains the largest grower of genetically modified crops in 2014 with 73.1 million hectares, roughly 40 per cent of the total and with a declining percentage share. Brazil is second, with 42.2 million hectares. Argentina is third, followed by India, Canada and China.

In South-East Asia, the Philippines placed 12th in the global ranking, with 800,000 hectares planted to biotech maize, while Myanmar took the 15th spot, with 300,000 hectares for cotton.

Biotech is the fastest growing crop technology that has been adopted by 18 million farmers, says the report. In 2014, nine out of ten of these farmers were small cultivators in developing countries. The adoption rate has seen a 100-fold increase since biotech crops were first planted in 1996.

The biotech global market was worth US$15.7 billion in 2014, making the controversial biotech crops a significant part of the global farming landscape.

Some biotech products recently approved for planting include “Innate” potato, which is said to have low acrylamide (a potential carcinogen in humans) and lower wastage of up to 40 per cent.

Another biotech product is insect-resistant eggplant in Bangladesh where the crop is the principal vegetable.

Biotech potato and eggplant join other biotech crops such as drought-tolerant sugar cane in Indonesia and biotech beans in Brazil, which both claim to have direct consumer benefits

“We are seeing not only industrial crops used for feed but food crops like biotech potato,” said Eufemio Rasco Jr., who retired in February as executive director of the Philippine Rice Research Institute and who also spoke in the media forum.

Food self-sufficiency has benefited from biotechnology without sacrificing the environment,” Rasco pointed out.

“Biotechnology is entering the mainstream,” noted Gil Saguiguit Jr., director of the Southeast Asia Regional Center for Graduate Study and Research in Agriculture (SEARCA), adding that he expects “more aggressive promotion” in the coming years.

>Link to the executive summary of the report

This article has been produced by SciDev.Net's South-East Asia & Pacific desk.

Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.